Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barriers to implementing a surgical beta-blocker protocol.

Michael N Cantor1, Valentina Lavarias, Steven Lam

  • 1Department of Medicine, Beth Israel Medical Center, New York City, NY, USA. michael.cantor@med.nyu.edu

Joint Commission Journal on Quality and Patient Safety
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do One Health Networks Compete, Coordinate, or Both? Insights from a Cross-Network Dialogue.

EcoHealth·2026
Same author

A rapid tool for understanding how knowledge users engage with research findings in research-for-development contexts.

Health research policy and systems·2026
Same author

The impact of social drivers of health on delayed time to breast cancer surgery.

British journal of cancer·2026
Same author

Association Between Age and Race and Cervical Cancer Stage.

O&G open·2025
Same author

Pork safety across Vietnam's traditional markets: Microbial contamination and vendor knowledge, attitudes, and practices.

Preventive veterinary medicine·2025
Same author

Revealing Solvent-Assisted Li<sup>+</sup> Transport in the Solid Electrolyte Interphase <i>operando</i>.

Journal of the American Chemical Society·2025
Same journal

Implementing the SSKIN Bundle in Home Healthcare: A Tool Tutorial for Reducing Pressure Injuries.

Joint Commission journal on quality and patient safety·2026
Same journal

How Collaboration Between Surgeons and Medical Oncologists Affects Outcomes for Patients with Pancreatic Cancer.

Joint Commission journal on quality and patient safety·2026
Same journal

Uneven Compassion and the Emotional Safety of the Healthcare Workforce.

Joint Commission journal on quality and patient safety·2026
Same journal

Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.

Joint Commission journal on quality and patient safety·2026
Same journal

Decreasing Herpes Simplex Virus (HSV) Testing Turnaround Time for Infants in a Hospital Setting: A Continuous Quality Improvement Project.

Joint Commission journal on quality and patient safety·2026
Same journal

Symptom Tracking in Primary Care: Designing and Testing an EHR-Embedded Safety-Net System.

Joint Commission journal on quality and patient safety·2026
See all related articles

Quality improvement programs for beta-blockade in at-risk patients show initial success but require ongoing education to sustain benefits. Sustained physician and staff education is crucial for effective beta-blocker implementation.

Area of Science:

  • Cardiology
  • Quality Improvement
  • Healthcare Management

Background:

  • Quality improvement (QI) programs aim to increase beta-adrenergic blockade use in at-risk patients.
  • Implementation barriers were identified in both academic and community hospital settings.

Purpose of the Study:

  • To evaluate the incidence and effectiveness of beta-blocker use before and after implementing a QI project.
  • To assess the impact of a standardized screening tool and education program on beta-blocker administration.

Main Methods:

  • Retrospective and prospective cohort study design.
  • Data collected at baseline, 6 weeks post-intervention, and 3-6 months post-intervention.
  • Comparison of beta-blocker use and efficacy between academic and community hospitals.

Related Experiment Videos

Main Results:

  • Beta-blocker administration increased from 56% to 79% post-intervention, with efficacy rising from 11% to 50%.
  • Administration rates declined to 61% by 3-6 months, while efficacy remained stable at 52%.
  • Significant variations in outcomes were noted between academic and community hospitals.

Conclusions:

  • Sustained physician and staff education is critical for the long-term success of QI programs for beta-blockade.
  • Ongoing educational support is essential to overcome implementation barriers and maintain therapeutic benefits.